Eradication of human medulloblastoma tumor xenografts with a combination of O6-benzyl-2'-deoxyguanosine and 1,3-bis(2-chloroethyl)-1-nitrosourea

Clinical Cancer Research

Volumn 5, Issue 11, 1999, Pages 3676-3681

  Kokkinakis, Demetrius M ^a   Moschel, Robert C ^b   Pegg, Anthony E ^c   Schold, S Clifford ^d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 O BENZYL 2' DEOXYGUANOSINE; 6 O BENZYLGUANINE; CARMUSTINE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BRAIN TUMOR; CANCER INHIBITION; CANCER THERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; EDEMA; HUMAN; HUMAN TISSUE; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; MEDULLOBLASTOMA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CARMUSTINE; CEREBELLAR NEOPLASMS; DEOXYGUANOSINE; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; MEDULLOBLASTOMA; MICE; MICE, NUDE; MITOSIS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; WEIGHT LOSS;

EID: 0032758273     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. 6-Alkylguanine DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1,3-bis(2-chloroethyl)-3-(trans-4-metylcyclohexyl)-1-nitrosourea. Proc. Natl. Acad. Sci. USA. 82: 2985-2989, 1985.
2. 6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res., 51: 3367-3372, 1991.
3. 6-Methylguanine-DNA methyltransferase activity and sensitivity of human tumor cell lines to bis-chloroethyl nitrosourea. Chin. Med. Sci. J., 8: 187-190, 1992.
4. 6-benzylgua-nine in vitro. Carcinogenesis (Lond.), 14: 1057-1060, 1993.
5. 6-alkylguanme-DNA alkyltransferase and N,N′-bis(2-chloroethyl)-N-nitrosourea. Biochem. Pharmacol., 50: 1141-1148, 1995.
6. 6-alkylguanine-DNA alkyltransferase. J. Cancer Res. Clin. Oncol., 121: 225-229, 1995.
7. 6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents. Cancer Res., 57: 5360-5368, 1997.
8. 6-benzyl-2′-deoxyguanosine and BCNU. Cancer Res., 56: 2076-2081, 1996.
9. Friedman, H., Dolan, E. M., Moschel, R. C., Pegg, A. E., Felker, G. M., Rich, J., Bigner, D. D., and Schold, S. C. Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme. J. Natl. Cancer Inst., 84: 1926-1931, 1992.
10. 6-benzylguanine enables the specific therapy of nitrosourea resistant human glioma xenografts in athymic rats with N,N′-bis(2-chloroethyl)-1-nitrosourea. Cancer Chemother. Pharmacol., 39: 307-316, 1997.
11. 6-benzylguanine for patients undergoing surgery for malignant gliomas. J. Clin. Oncol., 16: 3570-3575, 1998.
12. 6-alkylguanine-DNA alkyltransferase. J. Med. Chem., 35: 4486-4491, 1995.
13. 6-benzylguanine in rats and its metabolism by rat. Drug Metab. Dispos., 23: 1394-1399, 1995.
14. 6-Benzylguanine in humans: metabolic, pharmacokinetic and pharmacodynamic findings. Clin. Oncol., 16: 1803-1810, 1998.
15. 6-benzylguanine. Cancer Res., 56: 5571-5575, 1996.
16. 6-methylguanine-DMA methyltransferase gene in young patients with adult type cancers and functional assay. Carcinogenesis (Lond.), 16: 2441-2445, 1995.
17. 6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer. J. Clin. Oncol., 5: 209-213, 1999.
18. 6-benzylguanines: effects of metabolism. Cancer Chemother. Pharmacol., in press, 1999.
19. 6-benzyldeoxyguanosine in Sprague Dawley rats. Chem. Res. Toxicol., 7: 762-769, 1994.
20. 6-benzyl-2′-deoxyguanosine role of metabolism. In Vivo, 10: 297-306, 1996.
21. 6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis-2-chloroethyl-1-nitrosourea cytotoxicity. Biochem. Pharmacol., 48: 2127-2134, 1999.
22. 6-benzylquanine, streptozotocin, and 1,3-bis(2-chlorethyl)-l-nitrosourea in vitro and in vivo. Cancer Res., 54: 4371-4375, 1994.
23. Robins, M. J., Khwaja, T. A., and Robins, R. K. Purine nucleosides. XXIX. The synthesis of 2′-deoxy-L-adenosine and 2′-deoxy-L-guanosine and their α-anomers. J. Org. Chem., 35: 636-639, 1970.
24. 6-substituted-2′-deoxyguanosine residues at first, second, or both positions of codon 12. Chem. Res. Toxicol., 1: 391-397, 1988.
25. 6-methylguanine-DNA alkytransferase and sensitization of human tumor cell lines to nitrosoureas by methionine deprivation. Br. J. Cancer, 75: 779-788, 1997.
26. Hawk C. T., and Leary S. L. Formulatory for Laboratory Animals, p. 78. Ames, IA: Iowa State University Press, 1995.
27. Schabel, F. M., Johnston, T. P., McCaleb, G. S., Montgomery, J. A., Laster, W. R., and Skipper, H. E. Experimental evaluation of potential of anticancer agents. VIII. Effects of certain nitrosoureas on intracerebral L1210 leukemia. Cancer (Phila.), 23: 725-733, 1963.
28. Devita, V. T., Principles in chemotherapy. In: V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and Practices of Oncology, pp. 276-300. Philadelphia: Lippincott, 1989.
29. Levin, V. A., Prados, M. R., Wara, W. M., Davis, R. L., Gutin, P. H., Phillips, T. L., Lamborn, K., and Wilson, C. B. Radiation therapy with bromodeoxyuridine followed by CCNU, procarbazine and vincristine chemotherapy for the treatment of anaplastic gliomas. Int. J. Radiat. Oncol. Biol. Phys., 32: 75-83, 1995.
30. Fine, H. A. The basis for current treatment recommendations for malignant gliomas. J. Neuro-Oncol., 20: 111-120, 1994.
31. 6-Alkylguanine-DNA alkyltransferase activity in human brain and brain tumors. Carcinogenesis (Lond.), 5: 121-124, 1977.
32. Kohn, K. W. Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas. Cancer Res., 37: 1450-1454, 1977.
33. 6-(2-fluoroethyl)guanine and its probable role in the crosslinking of deoxyribonucleic acids. Biochem. Pharmacol., 32: 2011-2015, 1983.
34. 6-methylguanine-DNA methyltransferase. Nucleic Acid Res., 11: 7743-7758, 1983.
35. Brent, T. P. Suppression of cross-link formation in chloroethylnitrosourea treated DNA by an activity in extracts of human leukemic lymphoblasts. Cancer Res., 44: 1887-1892, 1984.
36. Belanisch, M., Pastor, M., Randall, T., Guerra, D., Kibitel, J., Alas, L., Li, B., Citron, M., Wasserman, P., White, A., Eyre, H., Jaeckle, K., Schulman, S., Rector, P., Prados, M., Coons, S., Shapiro, W., and Yarosh, D. Retrospective study of the correlation between DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. Cancer Res., 56: 783-788, 1996.
37. 6-methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study. J. Clin. Oncol., 16: 3310-3315, 1998.